2015 Cancer Drug Pricing Surveys
2015 Cancer Drug Pricing Surveys
$799.00
We performed two 5-question surveys of oncologists in the US to gauge the impact of cancer treatment costs on prescribed therapies.
Publisher: Biomedtracker
- Description
- Contents
- Samples
Overview
We performed two five-question surveys of U.S. oncologists to gauge the impact of cancer treatment costs on prescribed therapies. In these surveys, we asked oncologists questions about cancer treatment costs from multiple angles:
- Impact of drug pricing and value on cancer treatment plans
- Financial impact of cancer treatment on patients
- Frequency of conversations between physicians and cancer patients on drug/treatment pricing
- Hypothetical prescribing levels of new cancer drugs with given price and efficacy parameters.
Table of contents
Question 1: How many patients with the following types of cancers are currently in your care?
Question 2: What percentage of your current patients have each of the following as a primary payer?
Question 3: How often does cancer drug out-of-pocket cost to patients affect your treatment recommendations?
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
2015 PCSK9 Inhibitors Pulse 
Sign up to the